Table 1.General characteristics of subjects (n=698)
Characteristics |
Male |
Female |
Total |
p-value1
|
Age |
|
|
|
|
<15 |
132 (32.0) |
114 (40.0) |
246 (35.2) |
0.03 |
≥15 |
281 (68.0) |
171 (60.0) |
452 (64.8) |
|
Household income (won/mo) |
|
|
|
|
<500 000 |
372 (90.1) |
252 (88.4) |
624 (89.4) |
0.49 |
≥500 000 |
41 (9.9) |
33 (11.6) |
74 (10.6) |
|
Body mass index (kg/m2) |
|
|
|
|
<25 |
361 (87.4) |
256 (89.8) |
617 (88.4) |
0.33 |
≥25 |
52 (12.6) |
29 (10.2) |
81 (11.6) |
|
Residence |
|
|
|
|
Yeosu-si |
310 (75.1) |
169 (59.3) |
479 (68.6) |
<0.001 |
Namhae-gun |
103 (24.9) |
116 (40.7) |
219 (31.4) |
|
Table 2.Distribution of stress according to baseline characteristics of the study subjects (n=698)
Variables |
Psychosocial Well-being Index
|
p-value1
|
0-44 (n=509) |
45-54 (n=189) |
Age |
|
|
|
<15 |
197 (38.7) |
49 (25.9) |
0.002 |
≥15 |
312 (61.3) |
140 (74.1) |
|
Gender |
|
|
|
Male |
309 (60.7) |
104 (55) |
0.18 |
Female |
200 (39.3) |
85 (45) |
|
Household income (won/mo) |
|
|
|
<500 000 |
445 (87.4) |
179 (94.7) |
0.005 |
≥500 000 |
64 (12.6) |
10 (5.3) |
|
Body mass index (kg/m2) |
|
|
|
<25 |
453 (89.0) |
164 (86.8) |
0.42 |
≥25 |
56 (11.0) |
25 (13.2) |
|
Residence |
|
|
|
Yeosu-si |
347 (68.2) |
132 (69.8) |
0.67 |
Namhae-gun |
162 (31.8) |
57 (30.2) |
|
Table 3.Distribution of stress according to allergic symptoms of the study subjects (n=698)
Variables |
Psychosocial Well-being Index
|
p-value1
|
0-44 (n = 509) |
45-54 (n = 189) |
Wheeze |
58 (11.4) |
27 (14.3) |
0.30 |
Wheeze (last 1 year) |
26 (5.1) |
17 (9.0) |
0.06 |
Sleep disturbed by wheezing (last 1 year) |
8 (1.6) |
4 (2.1) |
0.74 |
School absence due to wheezing (last 1 year) |
4 (0.8) |
4 (2.1) |
0.22 |
Diagnosis of asthma |
27 (5.3) |
7 (3.7) |
0.38 |
Treatment of asthma (last 1 year) |
12 (2.4) |
2 (1.1) |
0.37 |
Rhinitis |
158 (31) |
87 (46) |
<0.001 |
Rhinitis (last 1 year) |
111 (21.8) |
60 (31.7) |
0.007 |
Rhinoconjunctivitis (last 1 year) |
6 (1.2) |
6 (3.2) |
0.10 |
Diagnosis of allergic rhinitis |
84 (16.5) |
37 (19.6) |
0.34 |
Treatment of allergic rhinitis (last 1 year) |
63 (12.4) |
25 (13.2) |
0.76 |
Itchy eczema |
46 (9.0) |
22 (11.6) |
0.30 |
Itchy eczema (last 1 year) |
31 (6.1) |
18 (9.5) |
0.12 |
Sleep disturbed by itchy rash (last 1 year) |
15 (2.9) |
7 (3.7) |
0.61 |
Diagnosis of itchy eczema |
66 (13.0) |
38 (20.1) |
0.02 |
Treatment of itchy eczema (last 1 year) |
32 (6.3) |
24 (12.7) |
0.01 |
Allergic conjunctivitis |
99 (19.4) |
55 (29.1) |
0.01 |
Allergic conjunctivitis (last 1 year) |
69 (13.6) |
42 (22.2) |
0.005 |
Diagnosis of conjunctivitis |
82 (16.1) |
48 (25.4) |
0.005 |
Treatment of conjunctivitis (last 1 year) |
47 (9.2) |
25 (13.2) |
0.12 |
Asthma2
|
75 (14.7) |
31 (16.4) |
0.59 |
Allergic rhinitis2
|
183 (36.0) |
100 (52.9) |
<0.001 |
Itchy eczema2
|
84 (16.5) |
42 (22.2) |
0.08 |
Allergic conjunctivitis2
|
151 (29.7) |
77 (40.7) |
0.01 |
Table 4.OR (95% CI) of allergic symptoms according to Psychosocial Well-being Index in a logistic regression model (n=698)
Outcome variables |
Crude OR (95% CI) |
Adjusted OR (95% CI)1
|
Wheeze |
1.006 (0.980, 1.033) |
1.004 (0.978, 1.031) |
Wheeze (last 1 year) |
1.023 (0.986, 1.060) |
1.021 (0.984, 1.059) |
Sleep disturbed by wheezing (last 1 year) |
1.007 (0.943, 1.075) |
1.009 (0.943, 1.080) |
School absence due to wheezing (last 1 year) |
1.040 (0.956, 1.131) |
1.050 (0.959, 1.149) |
Diagnosis of asthma |
0.975 (0.938, 1.014) |
0.975 (0.937, 1.014) |
Treatment of asthma (last 1 year) |
0.997 (0.939, 1.059) |
1.018 (0.955, 1.086) |
Rhinitis |
1.026 (1.007, 1.044) |
1.024 (1.005, 1.043) |
Rhinitis (last 1 year) |
1.015 (0.995, 1.036) |
1.013 (0.993, 1.034) |
Rhinoconjunctivitis (last 1 year) |
1.083 (1.005, 1.168) |
1.090 (1.008, 1.178) |
Diagnosis of allergic rhinitis |
0.990 (0.968, 1.012) |
0.990 (0.968, 1.013) |
Treatment of allergic rhinitis (last 1 year) |
0.994 (0.969, 1.019) |
0.993 (0.967, 1.019) |
Itchy eczema |
1.014 (0.985, 1.044) |
1.015 (0.985, 1.046) |
Itchy eczema (last 1 year) |
1.007 (0.974, 1.041) |
1.010 (0.976, 1.046) |
Sleep disturbed by itchy rash (last 1 year) |
1.000 (0.953, 1.049) |
0.996 (0.948, 1.047) |
Diagnosis of itchy eczema |
1.032 (1.007, 1.058) |
1.040 (1.013, 1.068) |
Treatment of itchy eczema (last 1 year) |
1.040 (1.007, 1.075) |
1.049 (1.013, 1.086) |
Allergic conjunctivitis |
1.027 (1.006, 1.049) |
1.020 (0.998, 1.042) |
Allergic conjunctivitis (last 1 year) |
1.034 (1.009, 1.059) |
1.026 (1.001, 1.052) |
Diagnosis of conjunctivitis |
1.036 (1.013, 1.060) |
1.031 (1.007, 1.055) |
Treatment of conjunctivitis (last 1 year) |
1.036 (1.006, 1.066) |
1.034 (1.003, 1.065) |
Asthma2
|
1.135 (0.719, 1.792) |
0.992 (0.968, 1.016) |
Allergic rhinitis2
|
2.002 (1.427, 2.807) |
1.019 (1.001, 1.038) |
Itchy eczema2
|
1.446 (0.954, 2.190) |
1.028 (1.004, 1.052) |
Allergic conjunctivitis2
|
1.630 (1.152, 2.306) |
1.019 (1.000, 1.039) |